HOME NEWS EARNINGS RESULTS PICKS STRATEGY BLOG CONTACT SUBSCRIBE LOGIN SUBSCRIBE JOIN FREE
LOADING
Price Investing Group
← Back to Research Watchlist
WVE
Wave Life Sciences Ltd
Healthcare Biotechnology · Singapore · Reports in usd
Market Cap: $1.20B
Market Cap
$1.20B
Enterprise Val
$616.1M
P/E Ratio
-5.87
P/B Ratio
2.32
Trailing PEG (1Y)
0.03
As Of
Apr 23, 2026

Overview & Key Metrics

Reporting period: Dec 31, 2025 · Q4 2025
Book Value$526.2M
Gross Margin100.00%
Profit Margin100.00%
Return on Equity-85.70%
Return on Assets-57.55%
Current Ratio6.47
Debt/Equity0.03
LT Debt/Equity0.02
Revenue Per Share0.10

Income Statement

Dec 31, 2025
Revenue$17.2M
Cost of Revenue$0.00
Gross Profit$17.2M
R&D$52.8M
SG&A$20.9M
Operating Expenses$73.7M
Operating Income-$56.5M
Interest Expense$0.00
Tax Expense$0.00
Net Income-$53.2M
EPS (Basic)$-0.29
EPS (Diluted)$-0.29
EBIT-$53.2M
EBITDA-$50.9M
Consolidated Income-$53.2M
Non-Controlling Interests$0.00

Balance Sheet

Dec 31, 2025
Cash & Equivalents$602.1M
Accounts Receivable$1.3M
Inventory$0.00
Current Assets$614.8M
LT Investments$3.8M
Property, Plant & Equipment$19.9M
Intangibles$0.00
Non-Current Assets$23.7M
Total Assets$638.5M
Accounts Payable$15.7M
Current Debt$8.4M
Current Liabilities$95.1M
LT Debt$9.4M
Non-Current Liabilities$17.2M
Total Liabilities$112.3M
Total Debt$17.8M
Retained Earnings-$1.33B
Shareholder Equity$518.4M
Shares Outstanding167,181,784

Cash Flow Statement

Dec 31, 2025
Operating Cash Flow-$33.8M
Investing Cash Flow$1.0K
Financing Cash Flow$439.7M
CapEx$1.0K
Free Cash Flow-$33.8M
Depreciation & Amort.$2.3M
Stock-Based Comp$7.4M
Acquisitions / Disposals$0.00
Investment Activity$0.00
Debt Issued/Repaid$0.00
Equity Issued/Repaid$392.8M
Dividends Paid$0.00
Net Change in Cash$405.9M
Data cached · Meta live · Daily live · Statements live · TTL 24h